Purpose The prognostic significance and treatment of lateral pelvic lymph node metastasis
(mLPLN) in rectal cancer patients receiving neoadjuvant chemoradiotherapy (nCRT) are not …

Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

Aims Selective lateral pelvic lymph node (LPN) dissection (LPND) following neoadjuvant
chemoradiotherapy (nCRT) for rectal cancer is widely recognized. This study aimed to …

Aim The need or otherwise for lateral pelvic node dissection (LPND) in rectal cancer patients
with clinical lateral pelvic node metastasis (LPNM) after neoadjuvant chemoradiotherapy …

BACKGROUND Lateral pelvic lymph node (LLN) metastasis (LLNM) occur in up to 28% of
patients with low rectal tumours. While prophylactic lateral pelvic lymph node dissection …

Background Synchronous lateral pelvic lymph node (LPLN) involvement occurs in a
significant number of patients with rectal cancer. The aim of this study is to determine the …

Aim It is still controversial whether the addition of lateral pelvic lymph node (LPN) dissection
(LPND) to total mesorectal excision (TME) can provide a survival benefit after neoadjuvant …

Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

Introduction The optimal management of patients with radiologically positive lateral pelvic
lymph nodes in locally advanced rectal cancer remains unclear. We compared local …

Background Although lateral pelvic node dissection (LPND) is recommended for rectal
cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to …